Ming Li

机构：University of Electronic Science and Technology of China, Peking University, Peking University Cancer Hospital, Peking University Shougang Hospital, Weifang University · ORCID：0000-0001-6291-9328

发表论文 486 篇 · 总被引 7921 次 · h-index 44

代表论文

• Proton‐Pump Inhibitor Use and Gastrointestinal Disease Risk: A Mendelian Randomization Study of Omics and Pharmacological Pathways (2025 · The FASEB Journal · 被引 4)
• A Real‐World Study of Resectable NSCLC Following Neoadjuvant Immunotherapy: Should Postoperative Adjuvant Immunotherapy be Recommended? (2025 · Thoracic Cancer · 被引 2)
• Bevacizumab plus chemotherapy versus chemotherapy in untreated advanced non-squamous non-small-cell lung cancer patients with brain metastases (BAP BRAIN): an open-label, randomized, multicenter, phase III study (2025 · ESMO Open · 被引 2)
• HSP90AA1 Facilitates Vascular Calcification in Chronic Kidney Disease Involving Chaperone-Mediated Autophagy (2026 · Biomedicines · 被引 1)
• Identification and prioritization of high-frequency biomarkers and therapeutic targets in gastric cancer trials (2025 · BMC Cancer · 被引 1)
• Effects of Biochar and Its Fractions on Soil Nitrogen Forms and Microbial Communities Under Freeze-Thaw Conditions (2025 · Agronomy · 被引 1)